D72.18
Eosinophilia in diseases classified elsewhere
Clinical Classification Guidelines
Code First
- underlying disease, such as:
- chronic myelomonocytic leukemia (C93.1-)
Medical Intelligence & Overview
Eosinophilia in Diseases Classified Elsewhere (ICD-10 Code D72.18) refers to an increase in eosinophils, a type of white blood cell, that occurs as part of various medical conditions. Eosinophils play a crucial role in the body's immune response, especially in fighting parasitic infections and participating in allergic reactions. When their numbers are elevated beyond normal levels, it can indicate the presence of underlying health issues. This code is used when eosinophilia is a feature of other recognized diseases, but not a primary diagnosis on its own. Understanding the causes, symptoms, and potential treatments of eosinophilia can help both healthcare professionals and patients manage the condition effectively.
Causes & Symptoms
Clinical Causes: Parasitic infections, especially those caused by worms and helminths Allergic reactions, such as asthma, hay fever, or drug allergies Autoimmune diseases like eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) Certain infectious diseases, including some fungal and bacterial infections Certain cancers, including some types of leukemia and lymphomas Eosinophilic gastrointestinal disorders, such as eosinophilic esophagitis Drug reactions causing eosinophilia Other systemic illnesses that involve immune system dysregulation
Key Symptoms: General fatigue and weakness Fever and chills if associated with infections Respiratory issues such as wheezing or difficulty breathing Skin rashes, hives, or itching Abdominal pain or gastrointestinal discomfort Swelling of lymph nodes Persistent cough or chest tightness Symptoms related to specific underlying conditions, like nasal congestion or sinus issues
Diagnostic & Treatment
Diagnosis Path: Diagnosing eosinophilia involves a combination of medical history, physical examination, and laboratory tests. Blood tests reveal elevated eosinophil counts, typically greater than 500 cells per microliter of blood. Identifying the underlying cause requires additional investigations, including stool tests for parasites, allergy testing, imaging studies, and sometimes biopsy procedures. It is essential to distinguish eosinophilia caused by other conditions to determine an appropriate management plan.
Treatment Protocols: Managing eosinophilia involves addressing the underlying disease or trigger. Treatment strategies may include: - Medications such as corticosteroids to reduce inflammation and eosinophil levels - Antiparasitic drugs if parasitic infection is identified - Antihistamines for allergic reactions - Immunosuppressive therapies for autoimmune conditions - Specific treatments targeted at underlying cancers or infections It is important to work closely with healthcare professionals to develop an individualized treatment plan, as the approach varies depending on the cause and severity of eosinophilia.
Clinical Advice & FAQs
Billing Guidance
Is D72.18 a billable ICD-10 code?
Yes, D72.18 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D72.18?
Clinical documentation must specify the nature of Eosinophilia in diseases classified elsewhere and any associated comorbidities for accurate reporting.
Cite this Clinical Reference